Extended duration of letermovir prophylaxis: how long is long enough?
- Author(s)
- Douglas, AP; Slavin, MA;
- Details
- Publication Year 2024-02,Volume 11,Issue #2,Page e88-e90
- Journal Title
- Lancet Haematology
- Publication Type
- Commentary
- Publisher
- Elsevier
- Keywords
- Humans; *Antiviral Agents/therapeutic use; Acetates; Quinazolines; *Hematopoietic Stem Cell Transplantation
- Department(s)
- Infectious Diseases; Health Services Research
- Publisher's Version
- https://doi.org/10.1016/s2352-3026(23)00368-x
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-03-05 04:47:27
Last Modified: 2024-03-05 04:47:58